Nurtec definition

Nurtec means, collectively, (a) the product known as Nurtec (rimegepant) that is approved by the U.S. Food and Drug Administration for marketing in the United States pursuant to NDA No. 212728 and.
View Source

Examples of Nurtec in a sentence

  • The proceeds of the Term Loan shall be applied by Borrowers (i) for the development, promotion and commercial launch of Nurtec ODT and (ii) for working capital and general corporate purposes of the Company and its Subsidiaries.

  • The proceeds of the Term Loans shall be applied by Borrowers (a) for the development, promotion and commercial launch of Nurtec ODT and (b) for working capital, pipeline development and general corporate purposes of the Company and its Subsidiaries.

  • Neither the Seller nor any of its Subsidiaries has experienced any significant failures in the manufacturing of Nurtec for commercial sale that has had or would result in, if such failure occurred again, a Material Adverse Effect.

  • Each Existing In License is a valid and binding obligation of the Seller (or, solely with respect to any existing In-License regarding Nurtec, such existing In-License is a valid and binding obligation of BPID) and the counterparty thereto.

  • The payment and reporting mechanics for Licensed Products under Sections 6.9 (Manner of Payment) through 6.15 (Taxes) shall apply to Net Sales of OTC Nurtec and Pfizer’s obligations with respect thereto.

  • Except as set forth in Section 6.8 (OTC Nurtec), following the expiration of the Royalty Term, on a country-by-country and Licensed Product-by-Licensed Product basis, no further royalties will be payable in respect of sales of such Licensed Product in such country and thereafter the license granted to Pfizer pursuant to Section 2.1 (Grant to Pfizer) shall become non-exclusive, fully paid-up, irrevocable, perpetual, and royalty-free; provided, however, [***].

  • Except as set forth on Schedule 3.1(k)(i), the Seller is the sole and exclusive registered owner (as recorded by the U.S. Patent and Trademark Office or other applicable Governmental Authority) of all of the Patent Rights, other than the Patent Rights in Nurtec, in which case, BPID is the sole and exclusive owner (as recorded by the U.S. Patent and Trademark Office or other applicable Governmental Authority) of such Patent Rights in Nurtec.

  • Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta, Kalydeco, Orkambi and Symdeko, Biogen’s Tysabri, AbbVie and ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇’▇ Imbruvica, ▇▇▇▇▇▇▇▇ and Pfizer’s Xtandi, GSK’s Trelegy, Novartis’ Promacta, ▇▇▇▇▇▇’s Nurtec ODT, ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇’▇ Tremfya, Roche’s Evrysdi, ▇▇▇▇▇▇’s Trodelvy, and 17 development- stage product candidates.

  • IndyCar branding will be in conjunction with existing annual sponsors including Nurtec and others.

  • Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta, Kalydeco, Orkambi and Symdeko, Biogen’s Tysabri, AbbVie and ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇’▇ Imbruvica, ▇▇▇▇▇▇▇▇ and ▇▇▇▇▇▇’s Xtandi, GSK’s Trelegy, Novartis’ Promacta, ▇▇▇▇▇▇’s Nurtec ODT, ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇’▇ Tremfya, Roche’s Evrysdi, ▇▇▇▇▇▇’s Trodelvy, and 12 development- stage product candidates.